WallStSmart

Agroz Inc. Ordinary Shares (AGRZ)vsBunge Global SA (BG)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Bunge Global SA generates 128405% more annual revenue ($80.55B vs $62.68M). AGRZ leads profitability with a 13.3% profit margin vs 0.8%. AGRZ trades at a lower P/E of 3.9x. AGRZ earns a higher WallStSmart Score of 60/100 (C+).

AGRZ

Buy

60

out of 100

Grade: C+

Growth: 8.0Profit: 8.5Value: 6.7Quality: 5.5
Piotroski: 3/9Altman Z: 1.91

BG

Buy

57

out of 100

Grade: C

Growth: 5.3Profit: 4.0Value: 3.3Quality: 5.0
Piotroski: 1/9Altman Z: 2.71
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for AGRZ.

BGSignificantly Overvalued (-49.2%)

Margin of Safety

-49.2%

Fair Value

$81.77

Current Price

$126.46

$44.69 premium

UndervaluedFair: $81.77Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AGRZ4 strengths · Avg: 9.8/10
P/E RatioValuation
3.9x10/10

Attractively priced relative to earnings

Price/BookValuation
1.4x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
320.2%10/10

Revenue surging 320.2% year-over-year

Return on EquityProfitability
25.6%9/10

Every $100 of equity generates 26 in profit

BG2 strengths · Avg: 9.0/10
Revenue GrowthGrowth
87.8%10/10

Revenue surging 87.8% year-over-year

Price/BookValuation
1.5x8/10

Reasonable price relative to book value

Areas to Watch

AGRZ4 concerns · Avg: 3.5/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Altman Z-ScoreHealth
1.914/10

Grey zone — moderate risk

Market CapQuality
$7.57M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

BG4 concerns · Avg: 3.5/10
PEG RatioValuation
1.714/10

Expensive relative to growth rate

P/E RatioValuation
33.5x4/10

Premium valuation, high expectations priced in

Return on EquityProfitability
4.3%3/10

ROE of 4.3% — below average capital efficiency

Profit MarginProfitability
0.8%3/10

0.8% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : AGRZ

The strongest argument for AGRZ centers on P/E Ratio, Price/Book, Revenue Growth. Revenue growth of 320.2% demonstrates continued momentum.

Bull Case : BG

The strongest argument for BG centers on Revenue Growth, Price/Book. Revenue growth of 87.8% demonstrates continued momentum.

Bear Case : AGRZ

The primary concerns for AGRZ are EPS Growth, Altman Z-Score, Market Cap.

Bear Case : BG

The primary concerns for BG are PEG Ratio, P/E Ratio, Return on Equity. Thin 0.8% margins leave little buffer for downturns.

Key Dynamics to Monitor

AGRZ profiles as a growth stock while BG is a hypergrowth play — different risk/reward profiles.

AGRZ is growing revenue faster at 320.2% — sustainability is the question.

AGRZ generates stronger free cash flow (-6M), providing more financial flexibility.

Monitor FARM PRODUCTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

AGRZ scores higher overall (60/100 vs 57/100) and 320.2% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Agroz Inc. Ordinary Shares

CONSUMER DEFENSIVE · FARM PRODUCTS · USA

Agroz Inc., an investment holding company, is a vertically integrated agricultural technology company in Malaysia. The company is headquartered in Petaling Jaya, Malaysia.

Bunge Global SA

CONSUMER DEFENSIVE · FARM PRODUCTS · USA

Bunge Limited is a global food and agribusiness company. The company is headquartered in St. Louis, Missouri.

Want to dig deeper into these stocks?